Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload

Summary: Activated factor X is a key component of the coagulation cascade, but whether it directly regulates pathological cardiac remodeling is unclear. In mice subjected to pressure overload stress, cardiac factor X mRNA expression and activity increased concurrently with cardiac hypertrophy, fibro...

Full description

Bibliographic Details
Main Authors: Xinji Guo, PhD, Mikhail A. Kolpakov, MD, PhD, Bahman Hooshdaran, PhD, William Schappell, BS, Tao Wang, MD, PhD, Satoru Eguchi, MD, PhD, Katherine J. Elliott, PhD, Douglas G. Tilley, PhD, A. Koneti Rao, MD, Patricia Andrade-Gordon, PhD, Matthew Bunce, PhD, Chintala Madhu, PhD, Steven R. Houser, PhD, Abdelkarim Sabri, PhD
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:JACC: Basic to Translational Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2452302X19303146
_version_ 1828367569950605312
author Xinji Guo, PhD
Mikhail A. Kolpakov, MD, PhD
Bahman Hooshdaran, PhD
William Schappell, BS
Tao Wang, MD, PhD
Satoru Eguchi, MD, PhD
Katherine J. Elliott, PhD
Douglas G. Tilley, PhD
A. Koneti Rao, MD
Patricia Andrade-Gordon, PhD
Matthew Bunce, PhD
Chintala Madhu, PhD
Steven R. Houser, PhD
Abdelkarim Sabri, PhD
author_facet Xinji Guo, PhD
Mikhail A. Kolpakov, MD, PhD
Bahman Hooshdaran, PhD
William Schappell, BS
Tao Wang, MD, PhD
Satoru Eguchi, MD, PhD
Katherine J. Elliott, PhD
Douglas G. Tilley, PhD
A. Koneti Rao, MD
Patricia Andrade-Gordon, PhD
Matthew Bunce, PhD
Chintala Madhu, PhD
Steven R. Houser, PhD
Abdelkarim Sabri, PhD
author_sort Xinji Guo, PhD
collection DOAJ
description Summary: Activated factor X is a key component of the coagulation cascade, but whether it directly regulates pathological cardiac remodeling is unclear. In mice subjected to pressure overload stress, cardiac factor X mRNA expression and activity increased concurrently with cardiac hypertrophy, fibrosis, inflammation and diastolic dysfunction, and responses blocked with a low coagulation-independent dose of rivaroxaban. In vitro, neurohormone stressors increased activated factor X expression in both cardiac myocytes and fibroblasts, resulting in activated factor X-mediated activation of protease-activated receptors and pro-hypertrophic and -fibrotic responses, respectively. Thus, inhibition of cardiac-expressed activated factor X could provide an effective therapy for the prevention of adverse cardiac remodeling in hypertensive patients. Key Words: activated coagulation factor X, cardiac hypertrophy, coagulation, fibrosis, protease-activated receptors, rivaroxaban
first_indexed 2024-04-14T05:59:31Z
format Article
id doaj.art-129e8e00131747649c682ca916df38a5
institution Directory Open Access Journal
issn 2452-302X
language English
last_indexed 2024-04-14T05:59:31Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series JACC: Basic to Translational Science
spelling doaj.art-129e8e00131747649c682ca916df38a52022-12-22T02:08:48ZengElsevierJACC: Basic to Translational Science2452-302X2020-01-01516983Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure OverloadXinji Guo, PhD0Mikhail A. Kolpakov, MD, PhD1Bahman Hooshdaran, PhD2William Schappell, BS3Tao Wang, MD, PhD4Satoru Eguchi, MD, PhD5Katherine J. Elliott, PhD6Douglas G. Tilley, PhD7A. Koneti Rao, MD8Patricia Andrade-Gordon, PhD9Matthew Bunce, PhD10Chintala Madhu, PhD11Steven R. Houser, PhD12Abdelkarim Sabri, PhD13Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaCardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaCardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaCardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaCardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaCardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaCardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaCenter of Translational Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaSol Sherry Thrombosis Center, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaJanssen Pharmaceutical, Spring House, PennsylvaniaJanssen Pharmaceutical, Spring House, PennsylvaniaJanssen Pharmaceutical, Spring House, PennsylvaniaCardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PennsylvaniaCardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania; Address for correspondence: Dr. Abdelkarim Sabri, Cardiovascular Research Center, Temple University, MERB 1045, 3500 North Broad Street, Philadelphia, Pennsylvania 19140.Summary: Activated factor X is a key component of the coagulation cascade, but whether it directly regulates pathological cardiac remodeling is unclear. In mice subjected to pressure overload stress, cardiac factor X mRNA expression and activity increased concurrently with cardiac hypertrophy, fibrosis, inflammation and diastolic dysfunction, and responses blocked with a low coagulation-independent dose of rivaroxaban. In vitro, neurohormone stressors increased activated factor X expression in both cardiac myocytes and fibroblasts, resulting in activated factor X-mediated activation of protease-activated receptors and pro-hypertrophic and -fibrotic responses, respectively. Thus, inhibition of cardiac-expressed activated factor X could provide an effective therapy for the prevention of adverse cardiac remodeling in hypertensive patients. Key Words: activated coagulation factor X, cardiac hypertrophy, coagulation, fibrosis, protease-activated receptors, rivaroxabanhttp://www.sciencedirect.com/science/article/pii/S2452302X19303146
spellingShingle Xinji Guo, PhD
Mikhail A. Kolpakov, MD, PhD
Bahman Hooshdaran, PhD
William Schappell, BS
Tao Wang, MD, PhD
Satoru Eguchi, MD, PhD
Katherine J. Elliott, PhD
Douglas G. Tilley, PhD
A. Koneti Rao, MD
Patricia Andrade-Gordon, PhD
Matthew Bunce, PhD
Chintala Madhu, PhD
Steven R. Houser, PhD
Abdelkarim Sabri, PhD
Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
JACC: Basic to Translational Science
title Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
title_full Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
title_fullStr Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
title_full_unstemmed Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
title_short Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
title_sort cardiac expression of factor x mediates cardiac hypertrophy and fibrosis in pressure overload
url http://www.sciencedirect.com/science/article/pii/S2452302X19303146
work_keys_str_mv AT xinjiguophd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT mikhailakolpakovmdphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT bahmanhooshdaranphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT williamschappellbs cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT taowangmdphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT satorueguchimdphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT katherinejelliottphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT douglasgtilleyphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT akonetiraomd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT patriciaandradegordonphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT matthewbuncephd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT chintalamadhuphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT stevenrhouserphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload
AT abdelkarimsabriphd cardiacexpressionoffactorxmediatescardiachypertrophyandfibrosisinpressureoverload